CPhI Worldwide-organized by UBM (part of Informa PLC)-announced the award entries for the 2018 CPhI Pharma Awards. The industry’s awards return for a 15th edition, with 17 categories honoring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies.
Categories include innovations across APIs, excipients, and formulations to drug delivery technologies, packaging, patient-centricity, contract services, and business performance focused awards.
This year the Bioprocessing & Manufacturing category-powered by the new bioLIVE event-is expected to see an increase in applications in light of the increased biologics and supply chain audiences now attending CPhI Worldwide. Among 2017’s most hotly contested categories were API Development, along with the fiercely competitive ‘Product Packaging’ and ‘Drug Delivery and Devices’ categories. Another increasingly significant category is the Corporate Social Responsibility award.
Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31st 2018-with shortlisted finalists announced August 28th, 2018. The winners will be unveiled during a ceremony at the Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide.
To apply please visit https://awards.cphi.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.